After many months of intensive preparatory work following a competitive call process, the Respiratory Syncytial Virus Consortium in Europe (RESCEU) was launched in January 2017.
The meeting was held in Sitges (Spain) and it was a memorable occasion to have about 100 participants from key stakeholder constituencies (RSV researchers ranging from epidemiologists and clinicians to more basic scientists; Public Health Agencies like ECDC, US CDC and WHO; esteemed members of the International Scientific Advisory Group, Patient Advisory Board and the Ethics Advisory Committee; agencies like EMA and PATH; funding agencies like BMGF; and the IMI project officer).
Follow this link to see the kick off meeting gallery.